NM_001080432.3:c.545G>C

Variant summary

Our verdict is Benign. The variant received -16 ACMG points: 0P and 16B. BP4_StrongBP6_Very_StrongBS2

The NM_001080432.3(FTO):​c.545G>C​(p.Gly182Ala) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000774 in 1,614,120 control chromosomes in the GnomAD database, including 13 homozygotes. In-silico tool predicts a benign outcome for this variant. 12/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.0042 ( 7 hom., cov: 32)
Exomes 𝑓: 0.00041 ( 6 hom. )

Consequence

FTO
NM_001080432.3 missense

Scores

8
9

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:4

Conservation

PhyloP100: 2.68

Publications

3 publications found
Variant links:
Genes affected
FTO (HGNC:24678): (FTO alpha-ketoglutarate dependent dioxygenase) This gene is a nuclear protein of the AlkB related non-haem iron and 2-oxoglutarate-dependent oxygenase superfamily but the exact physiological function of this gene is not known. Other non-heme iron enzymes function to reverse alkylated DNA and RNA damage by oxidative demethylation. Studies in mice and humans indicate a role in nervous and cardiovascular systems and a strong association with body mass index, obesity risk, and type 2 diabetes. [provided by RefSeq, Jul 2011]
FTO Gene-Disease associations (from GenCC):
  • lethal polymalformative syndrome, Boissel type
    Inheritance: AR Classification: STRONG, SUPPORTIVE, LIMITED Submitted by: Labcorp Genetics (formerly Invitae), G2P, Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -16 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0046047866).
BP6
Variant 16-53826285-G-C is Benign according to our data. Variant chr16-53826285-G-C is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 445384.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS2
High Homozygotes in GnomAd4 at 7 AR gene

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_001080432.3. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
FTO
NM_001080432.3
MANE Select
c.545G>Cp.Gly182Ala
missense
Exon 3 of 9NP_001073901.1
FTO
NM_001363894.2
c.545G>Cp.Gly182Ala
missense
Exon 3 of 10NP_001350823.1
FTO
NM_001363891.2
c.545G>Cp.Gly182Ala
missense
Exon 3 of 9NP_001350820.1

Ensembl Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
FTO
ENST00000471389.6
TSL:1 MANE Select
c.545G>Cp.Gly182Ala
missense
Exon 3 of 9ENSP00000418823.1
FTO
ENST00000637969.1
TSL:5
c.545G>Cp.Gly182Ala
missense
Exon 3 of 11ENSP00000490516.1
FTO
ENST00000637001.1
TSL:5
c.545G>Cp.Gly182Ala
missense
Exon 3 of 9ENSP00000489936.1

Frequencies

GnomAD3 genomes
AF:
0.00421
AC:
641
AN:
152200
Hom.:
7
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0141
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00268
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000103
Gnomad OTH
AF:
0.00335
GnomAD2 exomes
AF:
0.00107
AC:
269
AN:
251456
AF XY:
0.000817
show subpopulations
Gnomad AFR exome
AF:
0.0139
Gnomad AMR exome
AF:
0.000925
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000528
Gnomad OTH exome
AF:
0.000652
GnomAD4 exome
AF:
0.000415
AC:
606
AN:
1461802
Hom.:
6
Cov.:
33
AF XY:
0.000360
AC XY:
262
AN XY:
727202
show subpopulations
African (AFR)
AF:
0.0140
AC:
468
AN:
33478
American (AMR)
AF:
0.000984
AC:
44
AN:
44724
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
26136
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39700
South Asian (SAS)
AF:
0.0000348
AC:
3
AN:
86258
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
53420
Middle Eastern (MID)
AF:
0.000347
AC:
2
AN:
5768
European-Non Finnish (NFE)
AF:
0.0000171
AC:
19
AN:
1111926
Other (OTH)
AF:
0.00116
AC:
70
AN:
60392
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.481
Heterozygous variant carriers
0
45
90
135
180
225
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00422
AC:
643
AN:
152318
Hom.:
7
Cov.:
32
AF XY:
0.00426
AC XY:
317
AN XY:
74474
show subpopulations
African (AFR)
AF:
0.0141
AC:
588
AN:
41556
American (AMR)
AF:
0.00268
AC:
41
AN:
15304
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3472
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5188
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4822
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10618
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.000103
AC:
7
AN:
68038
Other (OTH)
AF:
0.00331
AC:
7
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.498
Heterozygous variant carriers
0
27
54
80
107
134
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000156
Hom.:
0
Bravo
AF:
0.00507
ESP6500AA
AF:
0.0125
AC:
55
ESP6500EA
AF:
0.000116
AC:
1
ExAC
AF:
0.00136
AC:
165
Asia WGS
AF:
0.000866
AC:
3
AN:
3478
EpiCase
AF:
0.00
EpiControl
AF:
0.0000593

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:3
Breakthrough Genomics, Breakthrough Genomics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:not provided

Feb 22, 2017
Center for Pediatric Genomic Medicine, Children's Mercy Hospital and Clinics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Jan 20, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Lethal polymalformative syndrome, Boissel type Benign:1
Apr 27, 2017
Illumina Laboratory Services, Illumina
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). No publications were found based on this search. Allele frequency data from public databases allowed determination this variant is unlikely to cause disease. Therefore, this variant is classified as likely benign.

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.11
BayesDel_addAF
Benign
-0.52
T
BayesDel_noAF
Benign
-0.51
CADD
Benign
22
DANN
Uncertain
1.0
DEOGEN2
Benign
0.042
T
Eigen
Uncertain
0.38
Eigen_PC
Uncertain
0.36
FATHMM_MKL
Uncertain
0.96
D
LIST_S2
Uncertain
0.92
D
MetaRNN
Benign
0.0046
T
MetaSVM
Benign
-0.73
T
MutationAssessor
Uncertain
2.0
M
PhyloP100
2.7
PrimateAI
Uncertain
0.50
T
PROVEAN
Benign
-1.4
N
REVEL
Benign
0.19
Sift
Benign
0.14
T
Sift4G
Uncertain
0.043
D
Polyphen
0.94
P
Vest4
0.34
MVP
0.84
MPC
0.70
ClinPred
0.025
T
GERP RS
4.2
PromoterAI
0.029
Neutral
Varity_R
0.072
gMVP
0.65
Mutation Taster
=86/14
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.020
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs61743972; hg19: chr16-53860197; API